Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 6:10 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 4,118 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Experimental 2 Clear all

Conditions: Healthy
Interventions: Carbohydrate blocking supplement (CBS), Placebo capsule; Dietary Supplement
Lead sponsor: dōTERRA International; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Pleasant Grove, Utah

Conditions: Gastroparesis, Diabetes Mellitus
Interventions: 5% dextrose in water, TZP-101; Drug
Lead sponsor: Tranzyme, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 6
States / cities: San Francisco, California • Anderson, Indiana • Kansas City, Kansas + 3 more

Conditions: Anorexia Nervosa, Body Image Disturbance, Interoception
Interventions: Floatation-REST, IFT, EFT; Behavioral
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 13 Years to 50 Years · Female only
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Advanced Cancer
Interventions: Psilocybin 25 mgs, Niacin 100mg, Psychotherapy; Drug · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • New York, New York

Conditions: Cocaine Use Disorder (CUD)
Interventions: Contingency Management (CM), Transcranial Magnetic Stimulation (TMS) Sham, Transcranial Magnetic Stimulation (TMS) experimental; Behavioral · Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Denture Retention
Interventions: Experimental Denture Adhesive 1, Experimental Denture Adhesive 2, Experimental Denture Adhesive 3, Poligrip Power Hold + Seal; Device
Lead sponsor: HALEON; Industry
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Acute, Post-operative Pain
Interventions: ST-2427, Placebo; Drug
Lead sponsor: SiteOne Therapeutics, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Opioid-use Disorder, Opioid Abuse, in Remission, Alcohol Use Disorder, Alcohol Use Disorder, in Remission
Interventions: Mindfulness Based Relapse Prevention; Behavioral
Lead sponsor: Clemson University; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Clemson, South Carolina • Greenville, South Carolina

Conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes
Interventions: coil-reinforced soft polymer indwelling cannula, soft Teflon indwelling catheter; Device
Lead sponsor: Capillary Biomedical, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Escondido, California

Conditions: Nausea
Interventions: Baxter Retching Faces (BARF) scale; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 4 Years to 12 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Healthy
Interventions: Nabumetone 750 mg tablets, single dose; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Morrisville, North Carolina

Conditions: Neoplasms, Breast
Interventions: lapatinib + capecitabine; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 159
States / cities: Huntsville, Alabama • Anchorage, Alaska • Glendale, Arizona + 135 more

Conditions: COVID-19
Interventions: mRNA-CR-04 vaccine 10μg, mRNA-CR-04 vaccine 30μg, mRNA-CR-04 vaccine 100μg, Placebo, mRNA-CR-04 vaccine 3μg; Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: San Diego, California • Melbourne, Florida • Peoria, Illinois + 1 more

Conditions: Colorectal Carcinoma, Familial Adenomatous Polyposis
Interventions: Biopsy Procedure, Biospecimen Collection, EP2/EP4 Antagonist TPST-1495, Esophagogastroduodenoscopy, Gastrointestinal Endoscopy, Questionnaire Administration; Procedure · Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Phoenix, Arizona • Rochester, Minnesota • Salt Lake City, Utah + 1 more

Conditions: Obesity
Interventions: Mental Contrasting- Individual, Mental Contrasting- Couple; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Type 2 Diabetes
Interventions: GSH Foods, Nutrition education about glutathione sources in the diet, Standard of care nutrition education for type 2 diabetes; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Metastatic Castration-resistant Prostate Cancer, Prostate Cancer
Interventions: acapatamab, Pembrolizumab, Etanercept, Cytochrome P450 (CYP) Cocktail; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 13
States / cities: Campbell, California • Duarte, California • Long Beach, California + 9 more

Conditions: Cancer of Rectum
Interventions: combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil); Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 5
States / cities: Lakewood, New Jersey • Livingston, New Jersey • New Brunswick, New Jersey + 2 more

Conditions: Suicide
Interventions: Implementation package (training and facilitation); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: Not listed
Enrollment: 1,086 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Neoplasms
Interventions: MEDI4736; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Coronary Artery Bypass Graft Surgery
Interventions: Regulating Mean Arterial Pressure during cardiopulmonary bypass; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 1994
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension
Interventions: mobile cognitive behavioral stress management intervention, Diploma in Stress Management course; Behavioral
Lead sponsor: ISA Associates, Inc.; Other
Eligibility: 18 Years and older · Male only
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: All Conditions
Interventions: PCF model; Other
Lead sponsor: Mathematica Policy Research, Inc.; Other
Eligibility: Not listed
Enrollment: 25,000,000 participants
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Heart Failure
Interventions: Control, Experimental, Experimental 2; Device
Lead sponsor: Piedmont Healthcare; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

Effects of a Novel Supplement on Glycemic Variability Measured by Continuous Glucose Monitoring

Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis

Interoceptive Mechanisms of Body Image Disturbance in Anorexia Nervosa

Psilocybin Therapy in Advanced Cancer

Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder

A Clinical Study to Assess the Effectiveness of Use of Three Experimental Denture Adhesives Compared to Using No-Adhesive

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427

Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders

Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS")

The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children

Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Exploring Beliefs and Behaviors About Weight Loss in Couples

Glutathione-rich Foods for Type 2 Diabetes

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Illinois Primary Health Care Association (COMMUNITY ASPIRE)

Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)

Using Mobile Stress Management to Reduce Hypertension in African American Men

Evaluation of the Primary Care First Model

Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonR